Switch theme
Sign up to access all valuation multiples
Dr Sulaiman Al Habib Medical Services Group is a healthcare operator. The company is engaged in establishing, operating, and managing hospitals, general and specialized medical complexes, dispensaries, health care centers, diagnostics centers as well as radiology centers. It is also involved in the import, wholesale and retail sales of medicines, medical products, cosmetics, and medical supplies and equipment. The company reports in three segments are Hospitals/ Healthcare Facilities, Pharmacies, and HMG Solutions / Others. The majority of the revenue is earned from the Hospitals/ Healthcare Facilities segment.
1993
n/a
LTM Revenue $3.2B
LTM EBITDA $792M
$27.9B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Dr. Sulaiman Al Habib has a last 12-month revenue of $3.2B and a last 12-month EBITDA of $792M.
In the most recent fiscal year, Dr. Sulaiman Al Habib achieved revenue of $3.0B and an EBITDA of $800M.
Dr. Sulaiman Al Habib expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Dr. Sulaiman Al Habib valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $2.5B | $3.0B | XXX | XXX | XXX |
| Gross Profit | $733M | $873M | XXX | XXX | XXX |
| Gross Margin | 29% | 29% | XXX | XXX | XXX |
| EBITDA | $681M | $800M | XXX | XXX | XXX |
| EBITDA Margin | 27% | 27% | XXX | XXX | XXX |
| Net Profit | $441M | $546M | XXX | XXX | XXX |
| Net Margin | 17% | 18% | XXX | XXX | XXX |
| Net Debt | $121M | $610M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Dr. Sulaiman Al Habib's stock price is SAR 283 (or $76).
Dr. Sulaiman Al Habib has current market cap of SAR 99.1B (or $26.5B), and EV of SAR 104B (or $27.9B).
See Dr. Sulaiman Al Habib trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $27.9B | $26.5B | XXX | XXX | XXX | XXX | $1.81 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Dr. Sulaiman Al Habib has market cap of $26.5B and EV of $27.9B.
Dr. Sulaiman Al Habib's trades at 8.8x LTM EV/Revenue multiple, and 35.2x LTM EBITDA.
Analysts estimate Dr. Sulaiman Al Habib's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Dr. Sulaiman Al Habib and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $27.9B | XXX | XXX | XXX |
| EV/Revenue | 9.3x | XXX | XXX | XXX |
| EV/EBITDA | 34.8x | XXX | XXX | XXX |
| P/E | 42.8x | XXX | XXX | XXX |
| P/E/Growth | 2.7x | XXX | XXX | XXX |
| EV/FCF | -121.6x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpDr. Sulaiman Al Habib's NTM/LTM revenue growth is 18%
Dr. Sulaiman Al Habib's revenue per employee for the last fiscal year averaged n/a, while opex per employee averaged n/a for the same period.
Over next 12 months, Dr. Sulaiman Al Habib's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Dr. Sulaiman Al Habib's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Dr. Sulaiman Al Habib and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | 18% | XXX | XXX | XXX | XXX |
| EBITDA Margin | 27% | XXX | XXX | XXX | XXX |
| EBITDA Growth | 17% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | 45% | XXX | XXX | XXX | XXX |
| Revenue per Employee | n/a | XXX | XXX | XXX | XXX |
| Opex per Employee | n/a | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | 1% | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | 1% | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| Opex to Revenue | 12% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Burjeel Holdings | XXX | XXX | XXX | XXX | XXX | XXX |
| PureHealth | XXX | XXX | XXX | XXX | XXX | XXX |
| Integral Diagnostics | XXX | XXX | XXX | XXX | XXX | XXX |
| Ramsay Health | XXX | XXX | XXX | XXX | XXX | XXX |
| Compass Pathways | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Dr. Sulaiman Al Habib acquired XXX companies to date.
Last acquisition by Dr. Sulaiman Al Habib was XXXXXXXX, XXXXX XXXXX XXXXXX . Dr. Sulaiman Al Habib acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was Dr. Sulaiman Al Habib founded? | Dr. Sulaiman Al Habib was founded in 1993. |
| Where is Dr. Sulaiman Al Habib headquartered? | Dr. Sulaiman Al Habib is headquartered in Saudi Arabia. |
| Is Dr. Sulaiman Al Habib publicy listed? | Yes, Dr. Sulaiman Al Habib is a public company listed on SAU. |
| What is the stock symbol of Dr. Sulaiman Al Habib? | Dr. Sulaiman Al Habib trades under 4013 ticker. |
| When did Dr. Sulaiman Al Habib go public? | Dr. Sulaiman Al Habib went public in 2020. |
| Who are competitors of Dr. Sulaiman Al Habib? | Similar companies to Dr. Sulaiman Al Habib include e.g. Burjeel Holdings, PureHealth, Integral Diagnostics, Ramsay Health. |
| What is the current market cap of Dr. Sulaiman Al Habib? | Dr. Sulaiman Al Habib's current market cap is $26.5B |
| What is the current revenue of Dr. Sulaiman Al Habib? | Dr. Sulaiman Al Habib's last 12-month revenue is $3.2B. |
| What is the current EBITDA of Dr. Sulaiman Al Habib? | Dr. Sulaiman Al Habib's last 12-month EBITDA is $792M. |
| What is the current EV/Revenue multiple of Dr. Sulaiman Al Habib? | Current revenue multiple of Dr. Sulaiman Al Habib is 8.8x. |
| What is the current EV/EBITDA multiple of Dr. Sulaiman Al Habib? | Current EBITDA multiple of Dr. Sulaiman Al Habib is 35.2x. |
| What is the current revenue growth of Dr. Sulaiman Al Habib? | Dr. Sulaiman Al Habib revenue growth between 2023 and 2024 was 18%. |
| Is Dr. Sulaiman Al Habib profitable? | Yes, Dr. Sulaiman Al Habib is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
